Ceva Animal Health has produced a new booklet explaining the discharge procedures for horses that have been treated with Equidronate (formerly called Tildren), a bisphosphonate infusion used for the treatment of bone spavin.
Ceva says the new booklet is designed for vets to give their clients to help convey the most effective post-treatment management protocol. It explains what Equidronate is, how it works and how it is administered. It goes on to cover how owners can help to monitor progress once exercise has commenced, by completing the specially created assessment forms contained within the booklet every couple of weeks.
According to the company, trials published earlier this year show that horses suffering lameness caused by bone spavin can show marked improvement following treatment with an Equidronate infusion, in combination with controlled exercise.
Copies of the new leaflet are available free of charge from your Ceva sales representative. Leaflets on understanding bone spavin, understanding navicular disease and understanding sacroiliac disease are also available.
PS: Whilst you're here, take a moment to see our latest job opportunities for vets.